FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Pierre Baumann

Research Profile

Chemicals & Drugs

Disorders

Depressive Disorder

Physiology

Procedures

Drug Therapy, Combination

Co-author Network

Publications

TOP 3
Eveline Jaquenoud Sirot; Michèle Jonzier-Perey; Klaus Kemmerling; Carlos A Mendonça Lima; Patrick Perrenoud; Pierre Vandel; Daniele F Zullino; Muriel Brocard; Séverine Crettol; Chin B Eap; Kerry Powell Golay; Sabine Harenberg; Henriette Hilleret; Pierre Baumann
Multicenter study on the clinical effectiveness, pharmacokinetics, and pharmacogenetics of mirtazapine in depression.
Georg Nikisch; Pierre Baumann; Tianmin Liu; Aleksander A Mathé
Quetiapine affects neuropeptide Y and corticotropin-releasing hormone in cerebrospinal fluid from schizophrenia patients: relationship to depression and anxiety symptoms and to treatment response.
Georg Nikisch; Pierre Baumann; Bernhard Kiessling; Michael Reinert; Georg Wiedemann; Jan Kehr; Aleksander A Mathé; Markus Piel; Frank Roesch; Heike Weisser; Peter Schneider; Andreas Hertel
Relationship between dopamine D2 receptor occupancy, clinical response, and drug and monoamine metabolites levels in plasma and cerebrospinal fluid. A pilot study in patients suffering from first-episode schizophrenia treated with quetiapine.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Pierre Baumann (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Eveline Jaquenoud Sirot; Michèle Jonzier-Perey; Klaus Kemmerling; Carlos A Mendonça Lima; Patrick Perrenoud; Pierre Vandel; Daniele F Zullino; Muriel Brocard; Séverine Crettol; Chin B Eap; Kerry Powell Golay; Sabine Harenberg; Henriette Hilleret; Pierre Baumann
Multicenter study on the clinical effectiveness, pharmacokinetics, and pharmacogenetics of mirtazapine in depression.
Journal of clinical psychopharmacology 2012;32(5):622-9.
2012: Georg Nikisch; Pierre Baumann; Tianmin Liu; Aleksander A Mathé
Quetiapine affects neuropeptide Y and corticotropin-releasing hormone in cerebrospinal fluid from schizophrenia patients: relationship to depression and anxiety symptoms and to treatment response.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2012;15(8):1051-61.
2010: Georg Nikisch; Pierre Baumann; Bernhard Kiessling; Michael Reinert; Georg Wiedemann; Jan Kehr; Aleksander A Mathé; Markus Piel; Frank Roesch; Heike Weisser; Peter Schneider; Andreas Hertel
Relationship between dopamine D2 receptor occupancy, clinical response, and drug and monoamine metabolites levels in plasma and cerebrospinal fluid. A pilot study in patients suffering from first-episode schizophrenia treated with quetiapine.
Journal of psychiatric research 2010;44(12):754-9.
2009: Eveline Jaquenoud Sirot; Branka Knezevic; Gina Perla Morena; Sabine Harenberg; Beatrice Oneda; Séverine Crettol; Nicolas Ansermot; Pierre Baumann; Chin B Eap
ABCB1 and cytochrome P450 polymorphisms: clinical pharmacogenetics of clozapine.
Journal of clinical psychopharmacology 2009;29(4):319-26.
2008: Georg Nikisch; Chin B Eap; Pierre Baumann
Citalopram enantiomers in plasma and cerebrospinal fluid of ABCB1 genotyped depressive patients and clinical response: a pilot study.
Pharmacological research : the official journal of the Italian Pharmacological Society 2008;58(5-6):344-7.
2008: Daniele Fabio Zullino; Bruno Schwartz; Romain Bilancioni; Pierre Baumann
Off-label utilization of antidepressants.
Acta medica (Hradec Králové) / Universitas Carolina, Facultas Medica Hradec Králové 2008;51(1):19-24.
2007: Aleksander A Mathé; Henriette Husum; Aram El Khoury; Patricia Jiménez-Vasquez; Susanne H M Gruber; Gitta Wörtwein; Georg Nikisch; Pierre Baumann; Hans Agren; Weronica Andersson; Asa Södergren; Francesco Angelucci
Search for biological correlates of depression and mechanisms of action of antidepressant treatment modalities. Do neuropeptides play a role?
Physiology & behavior 2007;92(1-2):226-31.
2006: Pierre Baumann; Remy Barbe; Assia Vabre-Bogdalova; Encarni Garran; Séverine Crettol; Chin B Eap
Epileptiform seizure after sertraline treatment in an adolescent experiencing obsessive-compulsive disorder and presenting a rare pharmacogenetic status.
Journal of clinical psychopharmacology 2006;26(6):679-81.
2006: P L Stephan; Eveline Jaquenoud Sirot; B Mueller; Chin B Eap; Pierre Baumann
Adverse drug reactions following nonresponse in a depressed patient with CYP2D6 deficiency and low CYP 3A4/5 activity.
Pharmacopsychiatry 2006;39(4):150-2.
2006: Pierre Baumann; Christoph Hiemke; Sven Ulrich; Gabriel Eckermann; H L Kuss; Gerd Laux; B Müller-Oerlingenhausen; Marie Luise Rao; Peter Riederer; Gerald Zernig
[Therapeutic drug monitoring (TDM) of psychotropic drugs: a consensus guideline of the AGNP-TDM group].
Revue médicale suisse 2006;2(67):1413-8, 1420-2, 1424-6.
2006: Pierre Baumann; Michèle Jonzier-Perey; Erik Paus; Georg Nikisch
Mirtazapine enantiomers in blood and cerebrospinal fluid.
Neuropsychobiology 2006;54(3):179-81.
2006: Eveline Jaquenoud Sirot; Jan Willem van der Velden; Katharina Rentsch; Chin B Eap; Pierre Baumann
Therapeutic drug monitoring and pharmacogenetic tests as tools in pharmacovigilance.
Drug safety : an international journal of medical toxicology and drug experience 2006;29(9):735-68.
2005: Séverine Crettol; Jean-Jacques Déglon; Jacques Besson; Marina Croquette-Krokkar; Isabelle Gothuey; Robert Hämmig; Martine Monnat; Hardy Hüttemann; Pierre Baumann; Chin B Eap
Methadone enantiomer plasma levels, CYP2B6, CYP2C19, and CYP2C9 genotypes, and response to treatment.
Clinical pharmacology and therapeutics 2005;78(6):593-604.
2005: Georg Nikisch; Aleksander A Mathé; Adelheid Czernik; Jutta Thiele; Jürgen Bohner; Chin B Eap; Hans Agren; Pierre Baumann
Long-term citalopram administration reduces responsiveness of HPA axis in patients with major depression: relationship with S-citalopram concentrations in plasma and cerebrospinal fluid (CSF) and clinical response.
Psychopharmacology 2005;181(4):751-60.
2005: Georg Nikisch; Hans Agren; Chin B Eap; Adelheid Czernik; Pierre Baumann; Aleksander A Mathé
Neuropeptide Y and corticotropin-releasing hormone in CSF mark response to antidepressive treatment with citalopram.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2005;8(3):403-10.
2005: Guido Bondolfi; Françoise Morel; Séverine Crettol; Fady Rachid; Pierre Baumann; Chin B Eap
Increased clozapine plasma concentrations and side effects induced by smoking cessation in 2 CYP1A2 genotyped patients.
Therapeutic drug monitoring 2005;27(4):539-43.
2005: Daniele Fabio Zullino; G Mayland; L G Schmidt; E Fähndrich; Waldemar Greil; A Horvath; Eckart Rüther; R Engel; H Hippius; Pierre Baumann
Prescribing practices in German and Swiss psychiatric university and in non-university hospitals: national differences.
International journal of clinical pharmacology and therapeutics 2005;43(7):339-49.
2005: Carlos A de Mendonça Lima; Pierre Baumann; Marlyse Brawand-Amey; Christian Brogli; Sylvie Jacquet; Nathalie Cochard; Kerry Powell Golay; Chin B Eap
Effect of age and gender on citalopram and desmethylcitalopram steady-state plasma concentrations in adults and elderly depressed patients.
Progress in neuro-psychopharmacology & biological psychiatry 2005;29(6):952-6.
2005: Jacques Fellay; Catia Marzolini; Laurent A Decosterd; Kerry Powell Golay; Pierre Baumann; Thierry Buclin; Amalio Telenti; Chin B Eap
Variations of CYP3A activity induced by antiretroviral treatment in HIV-1 infected patients.
European journal of clinical pharmacology 2005;60(12):865-73.
2005: Pierre Baumann; Sven Ulrich; Gabriel Eckermann; Manfred Gerlach; Hans-Joachim Kuss; Gerd Laux; Bruno Müller-Oerlinghausen; Marie Luise Rao; Peter Riederer; Gerald Zernig; Christoph Hiemke
The AGNP-TDM Expert Group Consensus Guidelines: focus on therapeutic monitoring of antidepressants.
Dialogues in clinical neuroscience 2005;7(3):231-47.
2004: Elio Ciusani; Daniele Fabio Zullino; Chin B Eap; Marlyse Brawand-Amey; Murielle Brocard; Pierre Baumann
Combination therapy with venlafaxine and carbamazepine in depressive patients not responding to venlafaxine: pharmacokinetic and clinical aspects.
Journal of psychopharmacology (Oxford, England) 2004;18(4):559-66.
2004: Pierre Baumann; Christoph Hiemke; Sven Ulrich; Gabriel Eckermann; I Gaertner; Manfred Gerlach; Hans-Joachim Kuss; Gerd Laux; Bruno Müller-Oerlinghausen; Marie Luise Rao; Peter Riederer; Gerald Zernig
The AGNP-TDM expert group consensus guidelines: therapeutic drug monitoring in psychiatry.
Pharmacopsychiatry 2004;37(6):243-65.
2004: Erik Paus; Michèle Jonzier-Perey; Nathalie Cochard; Chin B Eap; Pierre Baumann
Chirality in the new generation of antidepressants: stereoselective analysis of the enantiomers of mirtazapine, N-demethylmirtazapine, and 8-hydroxymirtazapine by LC-MS.
Therapeutic drug monitoring 2004;26(4):366-74.
2004: Messaoud Benmebarek; Corinne Devaud; Marianne Gex-Fabry; Kerry Powell Golay; Christian Brogli; Pierre Baumann; Bruno Gravier; Chin B Eap
Effects of grapefruit juice on the pharmacokinetics of the enantiomers of methadone.
Clinical pharmacology and therapeutics 2004;76(1):55-63.
2004: Chin B Eap; G Bouchoux; Norbert Scherbaum; M Gastpar; Kerry Powell Golay; Pierre Baumann
Determination of human plasma levels of levo-alpha-acetylmethadol and its metabolites by gas chromatography-mass spectrometry.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2004;805(1):141-6.
2004: Georg Nikisch; Aleksander A Mathé; Adelheid Czernik; Chin B Eap; Patricia Jiménez-Vasquez; Marlyse Brawand-Amey; Pierre Baumann
Stereoselective metabolism of citalopram in plasma and cerebrospinal fluid of depressive patients: relationship with 5-HIAA in CSF and clinical response.
Journal of clinical psychopharmacology 2004;24(3):283-90.
2004: Chin B Eap; Thierry Buclin; Elisabeth Hustert; Gabriela Bleiber; Kerry Powell Golay; Anne-Catherine Aubert; Pierre Baumann; Amalio Telenti; Reinhold Kerb
Pharmacokinetics of midazolam in CYP3A4- and CYP3A5-genotyped subjects.
European journal of clinical pharmacology 2004;60(4):231-6.
2004: Chin B Eap; Thierry Buclin; Gianni Cucchia; Daniele Fabio Zullino; Elisabeth Hustert; Gabriela Bleiber; Kerry Powell Golay; Anne-Catherine Aubert; Pierre Baumann; Amalio Telenti; Reinhold Kerb
Oral administration of a low dose of midazolam (75 microg) as an in vivo probe for CYP3A activity.
European journal of clinical pharmacology 2004;60(4):237-46.
2004: Chin B Eap; G Bouchoux; Kerry Powell Golay; Pierre Baumann
Determination of picogram levels of midazolam, and 1- and 4-hydroxymidazolam in human plasma by gas chromatography-negative chemical ionization-mass spectrometry.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2004;802(2):339-45.
2004: Pierre Baumann; Christoph Hiemke; Sven Ulrich; I Gaertner; Marie Luise Rao; Gabriel Eckermann; Manfred Gerlach; Hans-Joachim Kuss; Gerd Laux; Bruno Müller-Oerlinghausen; Peter Riederer; Gerald Zernig
Therapeutic monitoring of psychotropic drugs: an outline of the AGNP-TDM expert group consensus guideline.
Therapeutic drug monitoring 2004;26(2):167-70.
2004: Chin B Eap; Eveline Jaquenoud Sirot; Pierre Baumann
Therapeutic monitoring of antidepressants in the era of pharmacogenetics studies.
Therapeutic drug monitoring 2004;26(2):152-5.
2004: Chin B Eap; Stefan Bender; Eveline Jaquenoud Sirot; Gianni Cucchia; Michèle Jonzier-Perey; Pierre Baumann; Delphine Allorge; Franck Broly
Nonresponse to clozapine and ultrarapid CYP1A2 activity: clinical data and analysis of CYP1A2 gene.
Journal of clinical psychopharmacology 2004;24(2):214-9.
2004: Chin B Eap; Jacques Fellay; Thierry Buclin; Gabriela Bleiber; Kerry Powell Golay; Murielle Brocard; Pierre Baumann; Amalio Telenti
CYP3A activity measured by the midazolam test is not related to 3435 C >T polymorphism in the multiple drug resistance transporter gene.
Pharmacogenetics 2004;14(4):255-60.
2003: Yves Le Bloc'h; Brigitte Woggon; Hansjörg Weissenrieder; Marlyse Brawand-Amey; Jacques Spagnoli; Chin B Eap; Pierre Baumann
Routine therapeutic drug monitoring in patients treated with 10-360 mg/day citalopram.
Therapeutic drug monitoring 2003;25(5):600-8.
2003: Marc Shinderman; Sarz Maxwell; Marlyse Brawand-Amey; Kerry Powell Golay; Pierre Baumann; Chin B Eap
Cytochrome P4503A4 metabolic activity, methadone blood concentrations, and methadone doses.
Drug and alcohol dependence 2003;69(2):205-11.
2003: D Eich-Höchli; R Oppliger; Kerry Powell Golay; Pierre Baumann; Chin B Eap
Methadone maintenance treatment and St. John's Wort - a case report.
Pharmacopsychiatry 2003;36(1):35-7.
2003: Chin B Eap; Etienne Lessard; Pierre Baumann; Marlyse Brawand-Amey; Marie-Andrée Yessine; Gilles O'Hara; Jacques Turgeon
Role of CYP2D6 in the stereoselective disposition of venlafaxine in humans.
Pharmacogenetics 2003;13(1):39-47.
2002: Pierre Baumann; Daniele Fabio Zullino; Chin B Eap
Enantiomers' potential in psychopharmacology--a critical analysis with special emphasis on the antidepressant escitalopram.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2002;12(5):433-44.
2002: Daniele Fabio Zullino; P Delacrausaz; Pierre Baumann
[The place of SSRIs in the treatment of schizophrenia].
L'Encéphale 2002;28(5 Pt 1):433-8.
2002: Henriette Hilleret; Pierre Voirol; Philippe Bovier; Panteleimon Giannakopoulos; Daniele Fabio Zullino; Pierre Baumann; Christian Cédric Giroud; Laurent Rivier; Chin B Eap
Very long half-life of paroxetine following intoxication in an extensive cytochrome P4502D6 metabolizer.
Therapeutic drug monitoring 2002;24(4):567-9.
2002: Lina Steinacher; Pierre Vandel; Daniele Fabio Zullino; Chin B Eap; Marlyse Brawand-Amey; Pierre Baumann
Carbamazepine augmentation in depressive patients non-responding to citalopram: a pharmacokinetic and clinical pilot study.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2002;12(3):255-60.
2002: Daniele Fabio Zullino; D Delessert; Chin B Eap; Martin Preisig; Pierre Baumann
Tobacco and cannabis smoking cessation can lead to intoxication with clozapine or olanzapine.
International clinical psychopharmacology 2002;17(3):141-3.
2002: Stefan Begré; Ulrich von Bardeleben; Dieter Ladewig; Sylvie Jaquet-Rochat; Line Cosendai-Savary; Kerry Powell Golay; Markus Kosel; Pierre Baumann; Chin B Eap
Paroxetine increases steady-state concentrations of (R)-methadone in CYP2D6 extensive but not poor metabolizers.
Journal of clinical psychopharmacology 2002;22(2):211-5.
2002: Chin B Eap; Thierry Buclin; Pierre Baumann
Interindividual variability of the clinical pharmacokinetics of methadone: implications for the treatment of opioid dependence.
Clinical pharmacokinetics 2002;41(14):1153-93.
2002: Markus Kosel; Carmela Gnerre; Pierre Voirol; M Amey; B Rochat; Constantin Bouras; Bernard Testa; Pierre Baumann
In vitro biotransformation of the selective serotonin reuptake inhibitor citalopram, its enantiomers and demethylated metabolites by monoamine oxidase in rat and human brain preparations.
Molecular psychiatry 2002;7(2):181-8.
2001: Pierre-Alexandre Bart; PG Rizzardi; S Gallant; Kerry Powell Golay; Pierre Baumann; Giuseppe Pantaleo; Chin B Eap
Methadone blood concentrations are decreased by the administration of abacavir plus amprenavir.
Therapeutic drug monitoring 2001;23(5):553-5.
2001: Carmela Gnerre; Markus Kosel; Pierre Baumann; Pierre-Alain Carrupt; Bernard Testa
Interaction of psychotropic drugs with monoamine oxidase in rat brain.
The Journal of pharmacy and pharmacology 2001;53(8):1125-30.
2001: Daniele Fabio Zullino; Pierre Baumann
Lithium augmentation in depressive patients not responding to selective serotonin reuptake inhibitors.
Pharmacopsychiatry 2001;34(4):119-27.
2001: Chin B Eap; Guido Bondolfi; Daniele Fabio Zullino; L Savary-Cosendai; Kerry Powell Golay; Markus Kosel; Pierre Baumann
Concentrations of the enantiomers of fluoxetine and norfluoxetine after multiple doses of fluoxetine in cytochrome P4502D6 poor and extensive metabolizers.
Journal of clinical psychopharmacology 2001;21(3):330-4.
2001: Chin B Eap; Guido Bondolfi; Daniele Fabio Zullino; C Bryois; M Fuciec; L Savary; Michèle Jonzier-Perey; Pierre Baumann
Pharmacokinetic drug interaction potential of risperidone with cytochrome p450 isozymes as assessed by the dextromethorphan, the caffeine, and the mephenytoin test.
Therapeutic drug monitoring 2001;23(3):228-31.
2001: Chin B Eap; F Broly; A Mino; Robert Hämmig; Jean-Jacques Déglon; Claude Uehlinger; D Meili; AF Chevalley; Gilles Bertschy; Daniele Fabio Zullino; Markus Kosel; Martin Preisig; Pierre Baumann
Cytochrome P450 2D6 genotype and methadone steady-state concentrations.
Journal of clinical psychopharmacology 2001;21(2):229-34.
2001: Markus Kosel; M Amey; A C Aubert; Pierre Baumann
In vitro metabolism of citalopram by monoamine oxidase B in human blood.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2001;11(1):75-8.
2000: Chin B Eap; M Bourquin; J Martin; J Spagnoli; S Livoti; K Powell; Pierre Baumann; Jean-Jacques Déglon
Plasma concentrations of the enantiomers of methadone and therapeutic response in methadone maintenance treatment.
Drug and alcohol dependence 2000;61(1):47-54.
2000: Pierre Voirol; P F Hodel; Daniele Fabio Zullino; Pierre Baumann
Serotonin syndrome after small doses of citalopram or sertraline.
Journal of clinical psychopharmacology 2000;20(6):713-4.
2000: Chin B Eap; R Bertel-Laubscher; Daniele Fabio Zullino; M Amey; Pierre Baumann
Marked increase of venlafaxine enantiomer concentrations as a consequence of metabolic interactions: a case report.
Pharmacopsychiatry 2000;33(3):112-5.
2000: Chin B Eap; S Bender; M Gastpar; W Fischer; C Haarmann; K Powell; Michèle Jonzier-Perey; Nathalie Cochard; Pierre Baumann
Steady state plasma levels of the enantiomers of trimipramine and of its metabolites in CYP2D6-, CYP2C19- and CYP3A4/5-phenotyped patients.
Therapeutic drug monitoring 2000;22(2):209-14.
2000: Pierre Voirol; Michèle Jonzier-Perey; F Porchet; M J Reymond; Robert Janzer; Constantin Bouras; H W Strobel; Markus Kosel; Chin B Eap; Pierre Baumann
Cytochrome P-450 activities in human and rat brain microsomes.
Brain research 2000;855(2):235-43.
1999: C Felder; Claude Uehlinger; Pierre Baumann; K Powell; Chin B Eap
Oral and intravenous methadone use: some clinical and pharmacokinetic aspects.
Drug and alcohol dependence 1999;55(1-2):137-43.
1999: Pierre Voirol; C Rubin; C Bryois; Markus Kosel; T Buclin; Pierre Baumann
Pharmacokinetic consequences of a citalopram treatment discontinuation.
Therapeutic drug monitoring 1999;21(3):263-6.
1999: Chin B Eap; N Yasui; S Kaneko; Pierre Baumann; K Powell; K Otani
Effects of carbamazepine coadministration on plasma concentrations of the enantiomers of mianserin and of its metabolites.
Therapeutic drug monitoring 1999;21(2):166-70.
1998: Markus Kosel; Chin B Eap; M Amey; Pierre Baumann
Analysis of the enantiomers of citalopram and its demethylated metabolites using chiral liquid chromatography.
Journal of chromatography. B, Biomedical sciences and applications 1998;719(1-2):234-8.
1998: Pierre Baumann
Care of depression in the elderly: comparative pharmacokinetics of SSRIs.
International clinical psychopharmacology 1998;13 Suppl 5():S35-43.
1998: B Rochat; Markus Kosel; G Boss; Bernard Testa; M Gillet; Pierre Baumann
Stereoselective biotransformation of the selective serotonin reuptake inhibitor citalopram and its demethylated metabolites by monoamine oxidases in human liver.
Biochemical pharmacology 1998;56(1):15-23.
1998: Chin B Eap; G Bouchoux; M Amey; Nathalie Cochard; L Savary; Pierre Baumann
Simultaneous determination of human plasma levels of citalopram, paroxetine, sertraline, and their metabolites by gas chromatography-mass spectrometry.
Journal of chromatographic science 1998;36(7):365-71.
1998: Pierre Baumann; R Nil; G Bertschy; A Jecker; H Brändli; J Morand; A Kasas; O Vuagniaux; F Ramseier
A double-blind double-dummy study of citalopram comparing infusion versus oral administration.
Journal of affective disorders 1998;49(3):203-10.
1998: Pierre Voirol; A C Aubert; Michèle Jonzier-Perey; Pierre Baumann
An automated procedure for the determination of protein concentration in subcellular fractions.
Clinica chimica acta; international journal of clinical chemistry 1998;273(1):89-93.
1998: Guido Bondolfi; H Dufour; M Patris; J P May; U Billeter; Chin B Eap; Pierre Baumann
Risperidone versus clozapine in treatment-resistant chronic schizophrenia: a randomized double-blind study. The Risperidone Study Group.
The American journal of psychiatry 1998;155(4):499-504.
1998: C Bryois; C Rubin; J D Zbinden; Pierre Baumann
[Withdrawal syndrome caused by selective serotonin reuptake inhibitors: apropos of a case].
Praxis 1998;87(10):345-8.
1998: Chin B Eap; C A Lima; F Macciardi; B Woggon; K Powell; Pierre Baumann
Steady state concentrations of the enantiomers of mianserin and desmethylmianserin in poor and in homozygous and heterozygous extensive metabolizers of debrisoquine.
Therapeutic drug monitoring 1998;20(1):7-13.
1997: Gilles Bertschy; C Bryois; Guido Bondolfi; A Velardi; P Budry; D Dascal; C Martinet; D Baettig; Pierre Baumann
The association carbamazepine-mianserin in opiate withdrawal: a double blind pilot study versus clonidine.
Pharmacological research : the official journal of the Italian Pharmacological Society 1997;35(5):451-6.
1997: Chin B Eap; Gilles Bertschy; K Powell; Pierre Baumann
Fluvoxamine and fluoxetine do not interact in the same way with the metabolism of the enantiomers of methadone.
Journal of clinical psychopharmacology 1997;17(2):113-7.
1997: Pierre Baumann; Gilles Bertschy
Long-term treatment of depression: is there a use for depot antidepressants?
International clinical psychopharmacology 1997;12(2):77-80.
1997: B Rochat; M Amey; M Gillet; U A Meyer; Pierre Baumann
Identification of three cytochrome P450 isozymes involved in N-demethylation of citalopram enantiomers in human liver microsomes.
Pharmacogenetics 1997;7(1):1-10.
1997: F Ferreres; Gilles Bertschy; Pierre Baumann
Antidepressant treatment before hospitalization for major depression: often prescribed, often undertitrated.
Pharmacological research : the official journal of the Italian Pharmacological Society 1997;35(1):33-6.
1996: Guido Bondolfi; C Chautems; B Rochat; Gilles Bertschy; Pierre Baumann
Non-response to citalopram in depressive patients: pharmacokinetic and clinical consequences of a fluvoxamine augmentation.
Psychopharmacology 1996;128(4):421-5.
1996: Chin B Eap; Pierre Baumann
Analytical methods for the quantitative determination of selective serotonin reuptake inhibitors for therapeutic drug monitoring purposes in patients.
Journal of chromatography. B, Biomedical applications 1996;686(1):51-63.
1996: Gilles Bertschy; Chin B Eap; K Powell; Pierre Baumann
Fluoxetine addition to methadone in addicts: pharmacokinetic aspects.
Therapeutic drug monitoring 1996;18(5):570-2.
1996: Pierre Baumann; R Nil; A Souche; S Montaldi; D Baettig; S Lambert; C Uehlinger; A Kasas; M Amey; M Jonzier-Perey
A double-blind, placebo-controlled study of citalopram with and without lithium in the treatment of therapy-resistant depressive patients: a clinical, pharmacokinetic, and pharmacogenetic investigation.
Journal of clinical psychopharmacology 1996;16(4):307-14.
1996: Chin B Eap; N Gaillard; K Powell; Pierre Baumann
Simultaneous determination of plasma levels of fluvoxamine and of the enantiomers of fluoxetine and norfluoxetine by gas chromatography-mass spectrometry.
Journal of chromatography. B, Biomedical applications 1996;682(2):265-72.
1996: P Conus; Guido Bondolfi; Chin B Eap; F Macciardi; Pierre Baumann
Pharmacokinetic fluvoxamine-clomipramine interaction with favorable therapeutic consequences in therapy-resistant depressive patient.
Pharmacopsychiatry 1996;29(3):108-10.
1996: Pierre Baumann
Pharmacology and pharmacokinetics of citalopram and other SSRIs.
International clinical psychopharmacology 1996;11 Suppl 1():5-11.
1996: Chin B Eap; T W Guentert; M Schãublin-Loidl; M Stabl; L Koeb; K Powell; Pierre Baumann
Plasma levels of the enantiomers of thioridazine, thioridazine 2-sulfoxide, thioridazine 2-sulfone, and thioridazine 5-sulfoxide in poor and extensive metabolizers of dextromethorphan and mephenytoin.
Clinical pharmacology and therapeutics 1996;59(3):322-31.
1996: Chin B Eap; T Finkbeiner; Markus Gastpar; Norbert Scherbaum; K Powell; Pierre Baumann
Replacement of (R)-methadone by a double dose of (R,S)-methadone in addicts: interindividual variability of the (R)/(S) ratios and evidence of adaptive changes in methadone pharmacokinetics.
European journal of clinical pharmacology 1996;50(5):385-9.
1996: Guido Bondolfi; Pierre Baumann; H Dufour
Treatment-resistant schizophrenia: clinical experience with new antipsychotics.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 1996;6 Suppl 2():S21-5.
1995: Chin B Eap; L Koeb; K Powell; Pierre Baumann
Determination of the enantiomers of thioridazine, thioridazine 2-sulfone, and of the isomeric pairs of thioridazine 2-sulfoxide and thioridazine 5-sulfoxide in human plasma.
Journal of chromatography. B, Biomedical applications 1995;669(2):271-9.
1995: B Rochat; M Amey; Pierre Baumann
Analysis of enantiomers of citalopram and its demethylated metabolites in plasma of depressive patients using chiral reverse-phase liquid chromatography.
Therapeutic drug monitoring 1995;17(3):273-9.
1995: Pierre Baumann; B Rochat
Comparative pharmacokinetics of selective serotonin reuptake inhibitors: a look behind the mirror.
International clinical psychopharmacology 1995;10 Suppl 1():15-21.
1995: C Meylan; Guido Bondolfi; A C Aubert; Pierre Baumann
Reversible neutropenia during a cold: possible involvement of risperidone? A case report.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 1995;5(1):1-2; discussion 3.
1995: B Rochat; M Amey; H Van Gelderen; B Testa; Pierre Baumann
Determination of the enantiomers of citalopram, its demethylated and propionic acid metabolites in human plasma by chiral HPLC.
Chirality 1995;7(6):389-95.
1994: Gilles Bertschy; Pierre Baumann; Chin B Eap; D Baettig
Probable metabolic interaction between methadone and fluvoxamine in addict patients.
Therapeutic drug monitoring 1994;16(1):42-5.
1994: Chin B Eap; L Koeb; Pierre Baumann
Determination of trimipramine and its demethylated and hydroxylated metabolites in plasma by gas chromatography-mass spectrometry.
Journal of chromatography 1994;652(1):97-103.
1994: Chin B Eap; K Powell; D Campus-Souche; C Monney; D Baettig; W Taeschner; Pierre Baumann
Determination of the enantiomers of mianserin, desmethylmianserin, and 8-hydroxymianserin in the plasma and urine of mianserin-treated patients.
Chirality 1994;6(7):555-63.
1993: P Reymond; M Amey; A Souche; S Lambert; H Konrat; Chin B Eap; Pierre Baumann
Determination of plasma levels of citalopram and its demethylated and deaminated metabolites by gas chromatography and gas chromatography-mass spectrometry.
Journal of chromatography 1993;616(2):221-8.
1993: Chin B Eap; L Koeb; Pierre Baumann
Artifacts in the analysis of thioridazine and other neuroleptics.
Journal of pharmaceutical and biomedical analysis 1993;11(6):451-7.
1993: D Baettig; Guido Bondolfi; S Montaldi; M Amey; Pierre Baumann
Tricyclic antidepressant plasma levels after augmentation with citalopram: a case study.
European journal of clinical pharmacology 1993;44(4):403-5.
1992: Chin B Eap; L Koeb; Edith Holsboer-Trachsler; Pierre Baumann
Plasma levels of trimipramine and metabolites in four patients: determination of the enantiomer concentrations of the hydroxy metabolites.
Therapeutic drug monitoring 1992;14(5):380-5.
1992: Ursula Breyer-Pfaff; B Pfandl; K Nill; E Nusser; C Monney; M Jonzier-Perey; D Baettig; Pierre Baumann
Enantioselective amitriptyline metabolism in patients phenotyped for two cytochrome P450 isozymes.
Clinical pharmacology and therapeutics 1992;52(4):350-8.
1992: Pierre Baumann
Clinical pharmacokinetics of citalopram and other selective serotonergic reuptake inhibitors (SSRI).
International clinical psychopharmacology 1992;6 Suppl 5():13-20.
1992: Pierre Baumann; J W Meyer; M Amey; D Baettig; C Bryois; M Jonzier-Perey; L Koeb; C Monney; B Woggon
Dextromethorphan and mephenytoin phenotyping of patients treated with thioridazine or amitriptyline.
Therapeutic drug monitoring 1992;14(1):1-8.
1992: Chin B Eap; S Laurian; A Souche; L Koeb; P Reymond; T Buclin; Pierre Baumann
Influence of quinidine on the pharmacokinetics of trimipramine and on its effect on the waking EEG of healthy volunteers. A pilot study on two subjects.
Neuropsychobiology 1992;25(4):214-20.
1991: Chin B Eap; J F Fischer; Pierre Baumann
Variations in relative concentrations of variants of human alpha 1-acid glycoprotein after acute-phase conditions.
Clinica chimica acta; international journal of clinical chemistry 1991;203(2-3):379-85.
1991: Chin B Eap; A Souche; L Koeb; Pierre Baumann
Light-induced racemization: artifacts in the analysis of the diastereoisomeric pairs of thioridazine 5-sulfoxide in the plasma and urine of patients treated with thioridazine.
Therapeutic drug monitoring 1991;13(4):356-62.
1991: A Souche; S Montaldi; C Uehlinger; A Kasas; M J Reymond; P Reymond; Pierre Baumann; H Dufour
[Treatment of resistant depression with the citalopram-lithium combination. Methodology of a double-blind multicenter study and preliminary results].
L'Encéphale 1991;17(3):213-9.
1991: A Souche; Pierre Baumann; L Koeb; P Thermoz; Jean-Michel Azorin; H Dufour
[Treatment of depression by a combination of clomipramine and triiodothyronine].
L'Encéphale 1991;17(1):37-42.
1990: C B Eap; C Cuendet; Pierre Baumann
Binding of d-methadone, l-methadone, and dl-methadone to proteins in plasma of healthy volunteers: role of the variants of alpha 1-acid glycoprotein.
Clinical pharmacology and therapeutics 1990;47(3):338-46.
1990: J W Meyer; B Woggon; Pierre Baumann; U A Meyer
Clinical implications of slow sulphoxidation of thioridazine in a poor metabolizer of the debrisoquine type.
European journal of clinical pharmacology 1990;39(6):613-4.
1989: Pierre Baumann; C B Eap
Contribution of the variants of alpha 1-acid glycoprotein to its binding of drugs.
Progress in clinical and biological research 1989;300():379-97.
1988: C B Eap; C Cuendet; Pierre Baumann
Binding of amitriptyline to alpha 1-acid glycoprotein and its variants.
The Journal of pharmacy and pharmacology 1988;40(11):767-70.
1988: C B Eap; C Cuendet; Pierre Baumann
Orosomucoid (alpha-1 acid glycoprotein) phenotyping by use of immobilized pH gradients with 8 M urea and immunoblotting. A new variant encountered in a population study.
Human genetics 1988;80(2):183-5.
1988: Pierre Baumann; P Bosshart; G Gabris; M Gastpar; L Koeb; B Woggon
Acetylation of maprotiline and desmethylmaprotiline in depressive patients phenotyped with sulfamidine, debrisoquine, and mephenytoin.
Arzneimittel-Forschung 1988;38(2):292-6.
1988: C B Eap; C Cuendet; Pierre Baumann
Selectivity in the binding of psychotropic drugs to the variants of alpha-1 acid glycoprotein.
Naunyn-Schmiedeberg's archives of pharmacology 1988;337(2):220-4.
1986: Pierre Baumann; M Jonzier-Perey; L Koeb; P K Lê; D Tinguely; J Schöpf
Amitriptyline pharmacokinetics and clinical response: I. Free and total plasma amitriptyline and nortriptyline.
International clinical psychopharmacology 1986;1(2):89-101.
1986: Pierre Baumann; M Jonzier-Perey; L Koeb; A Küpfer; D Tinguely; J Schöpf
Amitriptyline pharmacokinetics and clinical response: II. Metabolic polymorphism assessed by hydroxylation of debrisoquine and mephenytoin.
International clinical psychopharmacology 1986;1(2):102-12.
1985: C Schnyder; Pierre Baumann; M Jonzier-Perey; L Koeb; J Wertheimer
[The use of low-dose amitriptyline in psychogeriatrics. A clinical, pharmacokinetic and pharmacogenetic study].
Schweizerische medizinische Wochenschrift 1985;115(33):1128-34.
1985: D Tinguely; M Jonzier; J Schöpf; L Koeb; Pierre Baumann
Determination of compliance with riboflavin in an antidepressive therapy.
Arzneimittel-Forschung 1985;35(2):536-8.
1985: D Tinguely; Pierre Baumann; M Conti; M Jonzier-Perey; J Schöpf
Interindividual differences in the binding of antidepressives to plasma proteins: the role of the variants of alpha 1-acid glycoprotein.
European journal of clinical pharmacology 1985;27(6):661-6.
1982: Pierre Baumann; D Tinguely; J Schöpf
Increase of alpha 1-acid glycoprotein after treatment with amitriptyline.
British journal of clinical pharmacology 1982;14(1):102-3.
1982: D Tinguely; Pierre Baumann; J Schöpf
Microprocedure to determine the polymorphic forms of acid alpha 1-glycoprotein in plasma.
Journal of chromatography 1982;229(2):319-25.
1982: Pierre Baumann; D Tinguely; L Koeb; J Schöpf; P K Le
On the relationship between free plasma and saliva amitriptyline and nortriptyline.
International pharmacopsychiatry 1982;17(3):136-46.